Skip to main content
SpringerLink
Log in

Acetazolamide and Cardiac Failure

  • Letter to the Editor
  • Published:
Clinical Drug Investigation Aims and scope Submit manuscript

A Letter to the Editor to this article was published on 07 May 2018

The Original Article was published on 30 September 2017

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Imiela T, Budaj A. Acetazolamide as add-on diuretic therapy in exacerbations of chronic heart failure: a pilot study. Clin Drug Investig. 2017;37(12):1175–81.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  2. Massumi RA, Evans JM. Studies on the continuous use of a carbonic anhydrase inhibitor (Diamox) in ambulatory patients. Am Heart J. 1955;49(4):626–32.

    Article  PubMed  CAS  Google Scholar 

  3. Hanley T, Platts MM. Acetazolamide (Diamox) in the treatment of congestive heart-failure. Lancet. 1956;270(6919):357–9.

    Article  PubMed  CAS  Google Scholar 

  4. Braveman WS, Dexter RL, Rubin AL. Diamox (acetazolamide) as an oral diuretic in ambulatory cardiac patients. Am Heart J. 1957;54(2):284–90.

    Article  PubMed  CAS  Google Scholar 

  5. Swenson ER. New insights into carbonic anhydrase inhibition, vasodilatation, and treatment of hypertensive-related diseases. Curr Hypertens Rep. 2014;16(9):467.

    Article  PubMed  CAS  Google Scholar 

  6. Spitzer KW, Skolnick RL, Peercy BE, Keener JP, Vaughan-Jones RD. Facilitation of intracellular H(+) ion mobility by CO(2)/HCO(3)(−) in rabbit ventricular myocytes is regulated by carbonic anhydrase. J Physiol. 2002;541(Pt 1):159–67.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  7. Pathak CL. Direct action of acetazolamide (Diamox) on heart. Arch Int Pharmacodyn. 1958;117(1–2):168–73.

    PubMed  CAS  Google Scholar 

  8. Schumacher DS, Müller-Mottet S, Hasler ED, et al. Effect of oxygen and acetazolamide on nocturnal cardiac conduction, repolarization, and arrhythmias in precapillary pulmonary hypertension and sleep-disturbed breathing. Chest. 2014;146(5):1226–36.

    Article  PubMed  Google Scholar 

  9. Zimmerman S, Achenbach S, Wolf M, Janka R, Marwan M, Mahler V. Recurrent shock and pulmonary edema due to acetazolamide medication after cataract surgery. Heart Lung. 2014;43(2):124–6.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology and Laboratory Medicine, Faculty of Medicine, The University of British Columbia, Vancouver, Canada

    Nevio Cimolai

  2. Department of Pathology and Laboratory Medicine, Children’s and Women’s Health, Centre of British Columbia, 4480 Oak Street, Vancouver, BC, V6H3V4, Canada

    Nevio Cimolai

Authors
  1. Nevio Cimolai
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nevio Cimolai.

Ethics declarations

Funding

No funding was used to prepare this letter.

Conflicts on interest

The author has no conflict of interest to declare.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cimolai, N. Acetazolamide and Cardiac Failure. Clin Drug Investig 38, 649–650 (2018). https://doi.org/10.1007/s40261-018-0653-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40261-018-0653-1

Search

Navigation